A patient infected with SARS-Cov-2 presents with DIHS syndrome induced by olanzapine: diagnostic difficulties
Article Category: Review
Publié en ligne: 08 oct. 2023
Pages: 99 - 106
Reçu: 12 mars 2023
Accepté: 10 août 2023
© 2023 Michalina Pinkosz et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
A detailed description of patient's blood morphology throughout the treatment process and additional key symptoms observed in the process
Days of hospitalization |
|
7 |
9 |
10 |
11 |
13 |
14 |
Parameter value in PB |
|
|
|
|
|
|
Leukocytes [103 /μl] |
9.77 |
7.47 |
6.03 |
9.38 |
5.9 |
6.27 |
Neutrophils [%] |
82.7 |
62.1 |
84.1 |
79 |
57.4 |
62.4 |
Eosinophils [%] |
1.6 |
12 |
2 |
1.5 |
13.4 |
8.8 |
Basophils [%] |
0.2 |
0.8 |
0 |
0.2 |
1 |
0.6 |
Lymphocytes [%] |
12 |
15.3 |
9.1 |
15.4 |
21.5 |
21.5 |
Monocytes [%] |
3.4 |
9.8 |
4.8 |
3.9 |
9.7 |
6.7 |
Erythrocytes [106 /μl] |
4 |
3.5 |
3 |
3.2 |
3.5 |
3.6 |
Hemoglobin [g/dl] |
11.2 |
10.4 |
8.5 |
9.3 |
10.1 |
10.3 |
Hematocrit [%] |
34.3 |
31.4 |
25.7 |
27.3 |
30.1 |
29.8 |
MCV [10−15 /μl] |
86.4 |
89 |
85.7 |
84.5 |
87 |
83.5 |
MCH [pg/cell] |
28.2 |
29.5 |
28.3 |
28.8 |
29.2 |
28.9 |
MCHC [g/dl] |
32.7 |
33.1 |
33.1 |
34.1 |
33.6 |
34.6 |
RDW-CV [%] |
12.9 |
14.9 |
13 |
13 |
14.1 |
13.8 |
PLT [10−15 /μl] |
310 |
365 |
181 |
228 |
305 |
322 |
MPV [10−15 /μl] |
11 |
11 |
12.7 |
12.9 |
10.6 |
10.9 |
AspAT [U/l] |
87 |
|
|
64 |
|
|
AlAT [U/l] |
109 |
|
|
97 |
|
|
CRP [mg/l] |
89.5 |
8.13 |
73.2 |
131 |
19.1 |
21.4 |
CK [U/l] |
|
|
|
1144 |
|
|